Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-939
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Representative Cyclophosphamide Novaplus Container Label Ndc 10019-938-25 (Image 02)
Cyclophosphamide Novaplus Representative Carton Label Panel 1 Ndc 10019-938-01 (Image 03)
Cyclophosphamide Novaplus Representative Container Ndc 10019-939-50 (Image 04)
Https://worksites.baxter.com/sites/rafilestore/spl/sgl_spl_2025/cyclophosphamide%20novaplus%20anda%20040745%20v15%20ha3001722%20-%20dl%20-%2009june5%20-%cyclophosphamide Novaplus Representative Carton Label 10019-939-01 (Image 05)
Cyclophosphamide Novaplus Representative Container Label 10019-942-10 (Image 06)
Cyclophosphamide Novaplus Representative Carton Label 10019-942-01 (Image 07)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.